Ai Ching Lim
27Patents
9h-index
39Co-inventors
71Inventor score
Filing activity: Jun 5, 2006 → Sep 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7858739B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 62 | Active |
| US7847062B2 | Pharmacokinetic modulation and compositions for modified FN3 polypeptides | Chemistry; Metallurgy | 59 | Active |
| US8324362B2 | Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 57 | Active |
| US8609613B2 | Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides | Chemistry; Metallurgy | 35 | Active |
| US9328157B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 26 | Active |
| US9862758B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 20 | Active |
| US7767206B2 | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto | Chemistry; Metallurgy | 18 | Active |
| US10851144B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 13 | Active |
| US8790648B2 | Methods of treating psoriasis using IL-17 receptor A antibodies | Chemistry; Metallurgy | 12 | Active |
| US9382318B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 7 | Active |
| US9593163B2 | Oncostatin M receptor antigen binding proteins | Chemistry; Metallurgy | 3 | Active |
| US9663571B2 | Oncostatin M receptor antigen binding proteins | Chemistry; Metallurgy | 3 | Active |
| US9073999B2 | Anti-IL-17 receptor A neutralizing antibodies | Chemistry; Metallurgy | 3 | Active |
| US10208122B2 | IL-17 receptor A antigen binding proteins | Chemistry; Metallurgy | 2 | Active |
| US9982054B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US10995131B2 | Libraries of modified fibronectin type III tenth domain-containing polypeptides | Chemistry; Metallurgy | 1 | Active |
| US9738721B1 | Oncostatin M receptor antigen binding proteins | Chemistry; Metallurgy | 1 | Active |
| US9309318B2 | Compositions relating to anti-IL-21 receptor antibodies | Chemistry; Metallurgy | 1 | Active |
| US10421813B2 | Oncostatin M receptor antigen binding proteins | Chemistry; Metallurgy | 1 | Active |
| US11059895B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 1 | Active |
| US11976103B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 0 | Active |
| US10184002B2 | Methods and compositions relating to anti-IL-21 receptor antibodies | Chemistry; Metallurgy | 0 | Active |
| US11965029B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US10227414B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US11858999B2 | IL-17 receptor A antigen binding proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.